This trial is to determine what dose of a drug called AZD1775 can safely be given in
combination with cisplatin before surgery and with chemo-radiotherapy after surgery in
patients with Head and Neck Cancer. The Investigators will also get some preliminary
information regarding the effectiveness of this combined treatment.